Reprint

Design and Synthesis of Organic Molecules as Antineoplastic Agents

Edited by
August 2020
210 pages
  • ISBN978-3-03936-666-8 (Hardback)
  • ISBN978-3-03936-667-5 (PDF)

This book is a reprint of the Special Issue Design and Synthesis of Organic Molecules as Antineoplastic Agents that was published in

Chemistry & Materials Science
Medicine & Pharmacology
Summary

This book is a collection of Special Issue articles with a multidisciplinary character, linking biology, medicine, and synthetic organic chemistry. The synthesis and full characterization of about 180 novel organic species, both of natural and synthetic origin, often designed with the support of in-silico studies, are set out in the book. In several articles, molecular hybridization approaches have been used as a successful multi-target strategy for the design and development of novel antitumor agents. Rigorous and careful biochemical studies ranging from in-vitro experiments on a plethora of human-cancer derived cell lines to in-vivo and ex-vivo studies allowed the authors to identify the molecular targets and gain useful information on structure–activity relationships (SAR). For this reason, this collection should interest many readers from different scientific fields.

Format
  • Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
anticancer; coumarin; hypoxia; 1,2,3-triazole; triterpenoids; betulinic acid; ursolic acid; oleanolic acid; amino group; guanidine group; cytotoxicity; apoptosis; cell cycle; privileged structure; pyrazoles; tubulin inhibitors; antitumor; antitumor agents; 3(2H)furanones; phenanthro[9,10-b]furanones; cyclooxygenase; cytotoxicity; anticancer; MCF-7; HSC-3; gefitinib; 5-fluorouracil; 3-methylidenechroman-4-ones; Michael addition; Horner–Wadsworth–Emmons olefination; cancer cell lines; apoptosis; hybrid molecules; quinolinequinones; naphtoquinones; 3,4,5-trimethoxyphenyl group; docking calculation; antitumor activity; cytotoxicity; pyrrolidine; carboxamide; anti-tumor activity; anti-cancer activity; cytotoxicity; apoptosis; bacterial biofilm; anti-bacterial activity; 9-hydroxystearic acid; methyl 9-hydroxystearate; methyl 9-aminostearate; cancer; pyrido[3′,2′:4,5]furo(thieno)[3,2-d]pyrimidin-8-amines; amination; furo[2,3-e]imidazo[1,2-c]pyrimidine; furo[2,3-e]pyrimido[1,2-c]pyrimidine; DNA methylation; sarcoma 180; antitumor activity; sulfur; anticancer; estrogen; cancer; pyridine; pyrimidine; 9-hydroxystearic acid; azelaic acid; osteosarcoma; molecular docking; 3-aryl-4-nitrothiochromans S,S-dioxide; l-Type Calcium Channels (LTCC); anticancer therapy; multidrug resistance (MDR1); in vitro experiments; cardiovascular activity; n/a